Skip to main content
Journal ArticleOPEN ACCESS

Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET

PLoS ONE (2016) 11(5)
DOI: 10.1371/journal.pone.0155635
16Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Purpose Tumor redox is an important factor for cancer progression, resistance to treatments, and a poor prognosis. The aim of the present study was to define tumor redox (over-reduction) using 62Cu-diacetyl-bis(N4 -methylthiosemicarbazone) (62 Cu-ATSM) PET and compare its prognostic potential in head and neck cancer (HNC) with that of 2-deoxy-2-[18 F]fluoro-Dglucose (18 F-FDG).

Cite

CITATION STYLE

APA

Tsujikawa, T., Asahi, S., Oh, M., Sato, Y., Narita, N., Makino, A., … Okazawa, H. (2016). Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET. PLoS ONE, 11(5). https://doi.org/10.1371/journal.pone.0155635

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free